GH3 and RC-4BC cell lines are not suitable as in vitro models to study prolactin modulation and AHR responsiveness in rat pituitary.

Published on Oct 1, 2019in Molecular and Cellular Endocrinology3.871
· DOI :10.1016/J.MCE.2019.110520
A.D. van den Brand2
Estimated H-index: 2
(UU: Utrecht University),
E. Rubinstein2
Estimated H-index: 2
+ 1 AuthorsM.B.M. van Duursen2
Estimated H-index: 2
(VU: VU University Amsterdam)
Sources
Abstract
Abstract Some environmental contaminants and pharmaceuticals increase the incidence of uterine tumors in toxicological studies with rats. These tumors can result from a hormonal imbalance due to rat-specific disrupted pituitary prolactin regulation, and are therefore of questionable relevance for humans. In this study we compared in vitro prolactin regulation in rat primary pituitary cells to that in pituitary cell lines, GH3 and RC-4BC. Moreover, we assessed the potential effects of aryl hydrocarbon receptor (AHR) activation on prolactin regulation by using two different AHR agonists, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and DELAQ, the N-deethylated minor metabolite of the pharmaceutical laquinimod. In rat primary pituitary cells, known prolactin stimulant thyrotropin-releasing hormone (TRH) marginally increased prolactin secretion (1.2-fold) and gene expression (1.3-fold). In contrast, synthetic dopamine receptor agonist quinpirole, a known inhibitor of prolactin release, significantly inhibited prolactin secretion (2.6-fold) and gene expression (3.6-fold). In GH3 cells, TRH strongly increased prolactin secretion (6.8-fold) and gene expression (30.8-fold), whereas quinpirole did not affect prolactin secretion nor gene expression. In RC-4BC cells, both TRH and quinpirole did not modulate prolactin secretion nor gene expression. Prolactin secretion and gene expression did not significantly change upon exposure to TCDD or DELAQ. However, DELAQ, but not TCDD, attenuated quinpirole-inhibited prolactin gene expression by 51% in primary pituitary cells. This study shows that pituitary prolactin regulation in rat primary pituitary cells in vitro is distinctly different from rat pituitary cell lines GH3 and RC-4BC. Therefore, effects on pituitary prolactin regulation in vitro should best be performed using rat primary pituitary cells. Additionally, AHR ligands may interact with rat pituitary prolactin regulation, but this appears to depend on the ligand and constitutive prolactin secretion. However, interpretation of the in vitro results with respect to occurrence of uterine tumors in rats should take the complex regulation of prolactin release in the pituitary into account as well as the in vivo hypothalamus-pituitary-gonadal (HPG) axis and its feedback loops.
📖 Papers frequently viewed together
44 Citations
1980
4 Authors (L. Ferland, ..., V. Raymond)
8 Citations
198142.78Nature
243 Citations
References41
Newest
#2Giancarlo ComiH-Index: 121
Last. Volker KnappertzH-Index: 22
view all 11 authors...
Background: Laquinimod 0.6 mg is a once-daily, oral, disease-modifying therapy in development for the treatment of multiple sclerosis (MS) that was investigated in two double-blind, placebo-controlled, phase 3 trials: ALLEGRO and BRAVO. Methods: Data from these studies were pooled to assess the safety profile of laquinimod versus placebo. Adverse events (AEs), laboratory value changes, and potential risks identified in preclinical studies were evaluated in participants in ALLEGRO and BRAVO treat...
11 CitationsSource
#1Michael S. Denison (UC Davis: University of California, Davis)H-Index: 75
#2Samantha C Faber (UC Davis: University of California, Davis)H-Index: 2
Abstract Ligand-dependent activation of the Ah receptor (AhR) can result in an extremely diverse spectrum of biological and toxic effects that occur in a ligand-, species- and tissue-specific manner. While the classical mechanism of AhR-dependent signal transduction is directly related to its ability to modulate gene expression, the dramatic diversity in responses observed following AhR activation or inhibition is inconsistent with a single molecular mechanism of AhR action. Recent studies have ...
43 CitationsSource
#1Stephen Safe (A&M: Texas A&M University)H-Index: 137
#2Yating Cheng (A&M: Texas A&M University)H-Index: 11
Last. Un Ho Jin (A&M: Texas A&M University)H-Index: 21
view all 3 authors...
Abstract The aryl hydrocarbon receptor (AhR) is overexpressed in some patients with different tumor types, and the receptor can be a negative or positive prognostic factor. There is also evidence from both in vivo and in vitro cell culture models that the AhR can exhibit tumor-specific pro-oncogenic and tumor suppressor-like functions and therefore can be treated with AhR antagonists or agonists, respectively. Successful clinical applications of AhR ligands will require the synthesis and develop...
46 CitationsSource
Laquinimod is an oral drug currently being evaluated for the treatment of relapsing, remitting, and primary progressive multiple sclerosis and Huntington’s disease. Laquinimod exerts beneficial activities on both the peripheral immune system and the CNS with distinctive changes in CNS resident cell populations, especially astrocytes and microglia. Analysis of genome-wide expression data revealed activation of the aryl hydrocarbon receptor (AhR) pathway in laquinimod-treated mice. The AhR pathway...
69 CitationsSource
#1Midori YoshidaH-Index: 24
#2Kaoru InoueH-Index: 18
Last. Miwa TakahashiH-Index: 17
view all 3 authors...
Endometrial adenocarcinoma in the uterine corpus is a malignant cancer that occurs in menopausal women and aged rodents. Because of the similarities in pathogenesis and morphology of endometrial adenocarcinoma in rodents and humans, prediction of the modes of action (MOA) in uterine carcinogenesis is important for extrapolation of rodent data to humans. Three MOAs have been accepted as major pathways for uterine carcinogenesis in rodents: 1) estrogenic activity, 2) increased serum 17beta-estradi...
10 CitationsSource
#1David Y. Lai (EPA: United States Environmental Protection Agency)H-Index: 15
#2Sam Kacew (U of O: University of Ottawa)H-Index: 27
Last. Wolfgang Dekant (University of Würzburg)H-Index: 59
view all 3 authors...
Due to potential consumer exposures, the toxicity of tetrabromobisphenol A (TBBPA) has been extensively studied. Reviews of TBBPA concluded no concerns regarding human health risks. The low toxicity of TBBPA is consistent with low bioavailability. However, some oral toxicity studies in rodents with TBBPA reported changes in thyroid hormone levels and a carcinogenicity study with TBBPA showed increased incidences of uterine tumors in rats. This review analyzes several modes of action (MoA) that m...
62 CitationsSource
#1K.A. SolakH-Index: 1
There is a wide range of alternative cellular test systems available, with the majority being derived from relevant organs and tissues that are frequently derived from human origin or embryonic life stages. Nevertheless, in vitro modeling of the full reproductive cycle to predict human reproductive and developmental risk remains a monumental challenge. The aim of this thesis was to study alterations by endocrine disrupting compounds (EDCs) in (part of) the hypothalamus-pituitary-ovary (HPO)-axis...
1 Citations
#1Arturo E. Gonzalez-Iglesias (FSU: Florida State University)H-Index: 18
#2Patrick A. Fletcher (FSU: Florida State University)H-Index: 9
Last. Joël Tabak (FSU: Florida State University)H-Index: 23
view all 7 authors...
The peptide oxytocin (OT) is secreted by hypothalamic neurons and exerts numerous actions related to reproduction. OT stimulation of prolactin secretion in female rats is important during the estrous cycle, pregnancy, and lactation. Here we report that OT also stimulates transients of intracellular Ca2+ concentration in somatotrophs and gonadotrophs as well as the release of GH and LH in a dose-dependent manner with EC50 values that closely correspond to the ligand affinity of the OT receptor (O...
22 CitationsSource
#1David Brott (AstraZeneca)H-Index: 9
#2Håkan H. A. S. Andersson (AstraZeneca)H-Index: 2
Last. Lewis B. Kinter (AstraZeneca)H-Index: 14
view all 8 authors...
Abstract Background Ticagrelor is an orally available, direct acting and reversible P2Y 12 receptor antagonist approved for treatment of acute coronary syndrome. The objectives of these studies were to (1) evaluate the Ticagrelor 2-year rat carcinogenicity bioassay data; (2) investigate potential mode of action (MOA) and (3) interpret human relevance. Methods The following studies were done (1) rat two-year carcinogenicity study in male and female rats, (2) in vitro and in vivo genotoxicity assa...
8 CitationsSource
#1J. Julie Kim (NU: Northwestern University)H-Index: 34
#2Takeshi Kurita (NU: Northwestern University)H-Index: 37
Last. Serdar E. Bulun (NU: Northwestern University)H-Index: 91
view all 3 authors...
Progesterone receptor (PR) mediates the actions of the ovarian steroid progesterone, which together with estradiol regulates gonadotropin secretion, prepares the endometrium for implantation, maintains pregnancy, and differentiates breast tissue. Separation of estrogen and progesterone actions in hormone-responsive tissues remains a challenge. Pathologies of the uterus and breast, including endometrial cancer, endometriosis, uterine fibroids, and breast cancer, are highly associated with estroge...
264 CitationsSource
Cited By3
Newest
#1Hongmei Wang (SEU: Southeast University)
#2Siyuan Bu (SEU: Southeast University)
Last. Junhong Dong (WMU: Weifang Medical University)
view all 6 authors...
Protein tyrosine phosphatase non-receptor type 5 (PTPN5), also called striatal-enriched protein tyrosine phosphatase (STEP), is highly expressed in neurons of the basal ganglia, hippocampus, cortex, and related structures, also in the pituitary. Gonadotropins are the key regulator of the reproduction in mammals. In this study, PTPN5 is detected to express in murine pituitary in a developmental manner. Moreover, the expression of PTPN5 in the pituitary is heavily reduced after ovary removal. Foll...
Source
#1Giovanna Giuseppina Altobelli (University of Naples Federico II)H-Index: 8
#2S. Van Noorden (Imperial College London)H-Index: 18
Last. Vincenzo Cimini (University of Naples Federico II)H-Index: 17
view all 6 authors...
PURPOSE The endocrine secretion of TSH is a finely orchestrated process controlled by the thyrotropin-releasing hormone (TRH). Its homeostasis and signaling rely on many calcium-binding proteins belonging to the "EF-hand" protein family. The Ca2+/calmodulin (CaM) complex is associated with Ca2+/CaM-dependent kinases (Ca2+/CaMK). We have investigated Ca2+/CaMK expression and regulation in the rat pituitary. METHODS The expression of CaMKII and CaMKIV in rat anterior pituitary cells was shown by i...
Source
#1Emilio J. Vélez (Western University College of Veterinary Medicine)H-Index: 12
#2Suraj Unniappan (Western University College of Veterinary Medicine)H-Index: 30
Nesfatin-1 (NESF) and NESF-like peptide (NLP), encoded in nucleobindin 2 and 1 (NUCB2 and NUCB1), respectively, are orphan ligands and metabolic factors. We hypothesized that NESF and NLP suppress growth hormone (GH) synthesis, and aimed to determine whether mammalian somatotrophs are a source and site of action of these peptides. Using immortalized rat somatotrophs (GH3 cells), NUCB expression was determined by qPCR, immunofluorescence and Western blot. NESF and NLP binding to GH3 cells was tes...
10 CitationsSource